Glenview Trust Co increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 5.6% in the first quarter, HoldingsChannel.com reports. The firm owned 123,234 shares of the medical equipment provider’s stock after buying an additional 6,572 shares during the period. Intuitive Surgical accounts for approximately 0.9% of Glenview Trust Co’s portfolio, making the stock its 25th largest holding. Glenview Trust Co’s holdings in Intuitive Surgical were worth $56,810,000 as of its most recent filing with the SEC.
Other institutional investors have also recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. boosted its position in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the period. Olistico Wealth LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Main Street Group LTD acquired a new position in Intuitive Surgical during the 1st quarter worth about $30,000. Laurel Wealth Advisors LLC acquired a new position in Intuitive Surgical during the 4th quarter worth about $31,000. Finally, Vermillion Wealth Management Inc. boosted its holdings in Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after acquiring an additional 25 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on ISRG shares. Deutsche Bank Aktiengesellschaft dropped their target price on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday, June 2nd. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Leerink Partners dropped their price objective on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a report on Friday. Barclays set a $651.00 target price on shares of Intuitive Surgical and gave the stock an “overweight” rating in a report on Thursday, April 23rd. Finally, Mizuho set a $500.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Wednesday, July 15th. Twenty-one equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $523.46.
Insider Activity at Intuitive Surgical
In other news, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director directly owned 239 shares of the company’s stock, valued at approximately $113,156.94. This represents a 67.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,169 shares of company stock valued at $3,059,135 over the last quarter. 0.60% of the stock is owned by insiders.
Intuitive Surgical Stock Up 2.2%
NASDAQ ISRG opened at $353.17 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $342.10 and a 52 week high of $603.88. The firm has a 50 day moving average of $413.94 and a two-hundred day moving average of $465.58. The stock has a market capitalization of $125.08 billion, a PE ratio of 40.45, a price-to-earnings-growth ratio of 2.80 and a beta of 1.46.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 17.09%. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.81 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 8.62 earnings per share for the current fiscal year.
Key Intuitive Surgical News
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Some market commentary argues ISRG’s recent correction may have reset expectations, with oversold technical conditions and improving earnings estimate revisions potentially setting up a near-term rebound. Down 15% in 4 Weeks, Here’s Why You Should You Buy the Dip in Intuitive Surgical (ISRG)
- Positive Sentiment: Zacks highlighted Intuitive Surgical as a trending stock with strong growth characteristics, saying the company’s fundamentals and growth profile may appeal to investors looking for long-term outperformance. 3 Reasons Growth Investors Will Love Intuitive Surgical (ISRG)
- Positive Sentiment: Another piece noted investor interest in ISRG remains elevated, suggesting the stock is staying on traders’ radar even after recent weakness. Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
- Neutral Sentiment: Commentary focused on whether investors should prioritize Intuitive Surgical’s current robot sales or its longer-term growth opportunity, reinforcing the debate around valuation versus future expansion. What’s More Important For Intuitive Surgical: Today’s Robots Or Tomorrow’s Growth?
- Negative Sentiment: Several analyst updates were cautious, with firms including Stifel, Sanford C. Bernstein, and Citigroup lowering price targets or expectations, which likely added to the selling pressure on ISRG. Stifel Nicolaus Lowers Intuitive Surgical (NASDAQ:ISRG) Price Target to $550.00
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
